Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease (IBD) to be used for a "treat...
Main Authors: | Peyrin-Biroulet, L, Sandborn, W, Sands, B, Reinisch, W, Bemelman, W, Bryant, R, D'Haens, G, Dotan, I, Dubinsky, M, Feagan, B, Fiorino, G, Gearry, R, Krishnareddy, S, Lakatos, P, Loftus, E, Marteau, P, Munkholm, P, Murdoch, T, Ordás, I, Panaccione, R, Riddell, R, Ruel, J, Rubin, D, Samaan, M, Siegel, C, Silverberg, MS, Stoker, J, Schreiber, S, Travis, S, Van Assche, G, Danese, S, Panes, J, Bouguen, G, O'Donnell, S, Pariente, B, Winer, S, Hanauer, S, Colombel, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Nature Publishing Group
2015
|
Registos relacionados
-
The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
Por: Sandborn, W, et al.
Publicado em: (2016) -
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
Por: Peyrin-Biroulet, L, et al.
Publicado em: (2012) -
Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative
Por: Danese, S, et al.
Publicado em: (2015) -
Development of an index to define overall disease severity in IBD
Por: Siegel, C, et al.
Publicado em: (2016) -
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
Por: D'Haens, G, et al.
Publicado em: (2009)